IP Library › Granted Patent US 9,492,584
Granted Patent B2
US 9,492,584 · App. 13/511,176 · Granted Nov 15, 2016

Post-charging of zeolite doped plastics with antimicrobial metal ions

Inventors: Joseph J. Crudden (Hudson, NH); Derrick Johns (Austin, TX)
Assignee: DiFusion Technologies, Inc.
A61L27/10A61L27/446A61L27/54A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,492,584
App. No.
13/511,176
Granted
Nov 15, 2016
Kind
B2
Abstract

Methods of post-loading ceramic particles with antimicrobial metal cations are disclosed. In certain embodiments, the post-loaded particles are zeolites, wherein the zeolites have been incorporated into a resin and the combination is used as an implantable device. In certain embodiments, the polymer is a thermoplastic polymer such as polyaryletheretherketone (PEEK). In certain embodiments, the source of antimicrobial activity includes ion-exchangeable cations contained in a zeolite. In certain embodiments, disclosed are methods of imparting antimicrobial activity to devices by controlling the delivery of certain cations through ion-exchange via a zeolite incorporated in the device.

Claims (15)

1. A method of post-charging ceramic particles with antimicrobial metal cations, comprising incorporating uncharged A-type zeolite particles having a three dimensional skeletal structure represented by the formula: XM 2/n O·Al 2 O 3 ·YSiO 2 ·ZH 2 O, wherein M represents an ion-exchangeable ion, n represents the atomic valency of the ion-exchangeable ion, X and Y represent coefficients of a metal oxide of an ion-exchangeable ion and silica dioxide respectively, and Z represents the number of water of crystallization into a thermoplastic polymer, thereafter charging said zeolite particles with one or more metal cations, and establishing the rate of release of said one or more metal ions from said zeolite particles in the thermoplastic polymer; wherein the amount of said uncharged A-type zeolite particles incorporated into said thermoplastic polymer, and the amount of said one or more metal cations charged to said zeolite particles, are effective to achieve antimicrobial activity when said thermoplastic polymer is implanted in the body of a patient and contacts bodily tissue or fluid to release said one or more metal cations from said thermoplastic polymer via ion-exchange.

2. The method of claim 1 , wherein said one or more metal cations are selected from the group consisting of silver, zinc and copper.

3. The method of claim 1 , further comprising forming said zeolite particles and thermoplastic polymer into an implant having a surface which contacts body tissue or fluid when implanted, and wherein at least some of said zeolite particles are present at said surface and capable of releasing said metal cations in an antimicrobially effective amount.

4. The method of claim 1 , wherein said metal cations are present at a level less than the ion-exchange capacity of the zeolite particles.

5. A method of imparting antimicrobial activity to a device by controlling the release of antimicrobial cations from said device through ion-exchange, comprising incorporating A-type zeolite particles having a three dimensional skeletal structure represented by the formula: XM 2/n O·Al 2 O 3 ·YSiO 2 ·ZH 2 O, wherein M represents an ion-exchangeable ion, n represents the atomic valency of the ion-exchangeable ion, X and Y represent coefficients of a metal oxide of an exchangeable ion and silica dioxide respectively, and Z represents the number of water of crystallization into a thermoplastic polymer, subsequently charging said zeolite particles with one or more metal cations, and establishing the rate of release of said one or more metal ions from said zeolite particles in the thermoplastic polymer; wherein the amount of said uncharged A-type zeolite particles incorporated into said thermoplastic polymer, and the amount of said one or more metal cations charged to said zeolite particles, are effective to achieve antimicrobial activity when said thermoplastic polymer is implanted in the body of a patient and contacts bodily tissue or fluid to release said one or more metal cations from said thermoplastic polymer via ion-exchange.

6. The method of claim 5 , wherein said metal cations comprise silver.

7. The method of claim 1 or 5 , wherein said thermoplastic polymer comprises reinforced PEEK.

8. The method of claim 7 , wherein said reinforced PEEK is carbon fiber-reinforced PEEK.

9. The method of claim 1 , wherein said thermoplastic polymer comprises PEEK that has a porosity between 50% and 85% by volume of said PEEK.

10. A method of forming an implant which comprises zeolite particles with antimicrobial metal cations, said implant having a surface, said method comprising:

a. incorporating uncharged A-type zeolite particles having a three dimensional skeletal structure represented by the formula: XM 2/n O·Al 2 O 3 ·YSiO 2 ·ZH 2 O, wherein M represents an ion-exchangeable ion, n represents the atomic valency of the ion-exchangeable ion, X represents a coefficient of a metal oxide of an ion-exchangeable ion and Y represents a coefficient of silica dioxide, and Z represents the number of water of crystallization into a thermoplastic polymer such that at least some of said zeolite particles are present at said implant surface;

b. forming said zeolite particles and thermoplastic polymer into an implant having a surface which contacts body tissue or fluid when implanted into a living body;

c. providing an infusion solution comprising antimicrobial metal cation salt and nitric acid;

d. exposing said implant to said infusion solution to load said zeolite particles with said antimicrobial metal cation and to etch said implant surface with said acid; and

establishing the rate of release of said one or more metal ions from said zeolite particles in the thermoplastic polymer; wherein said zeolite particles at said implant surface are capable of releasing said metal cations in an antimicrobially effective amount when said surface contacts said body tissue or fluid.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE USE OF THE REGISTERED DELAWARE FICTITIOUS BUSINESS NAME TO THE DELAWARE CORPORATE NAME PREVIOUSLY RECORDED ON REEL 049782 FRAME 0823. ASSIGNOR(S) HEREBY CONFIRMS THE SALE, ASSIGNMENT AND TRANSFER TO DIFUSION, INC. OUR ENTIRE RIGHT, TITLE AND INTEREST IN THE INVENTION AND PATENT. Recorded Jul 29, 2019
From: DIFUSION, INC. D/B/A DIFUSION TECHNOLOGIES, INC.
To: DIFUSION, INC.
Reel/Frame 049896/0069 →
CORRECTIVE ASSIGNMENT TO CORRECT THE USE OF THE REGISTERED DELAWARE FICTITIOUS BUSINESS PREVIOUSLY RECORDED AT REEL: 049782 FRAME: 0464. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 29, 2019
From: DIFUSION, INC. D/B/A DIFUSION TECHNOLOGIES, INC.
To: DIFUSION, INC.
Reel/Frame 049964/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2012
From: CRUDDEN, JOSEPH J.; JOHNS, DERRICK
To: DIFUSION TECHNOLOGIES, INC.
Reel/Frame 028875/0808 →
Continuity (3)
Provisional Application 61264289 · Nov 25, 2009
Provisional Application 61300631 · Feb 2, 2010
Related Publication 20120315340A1 · Dec 13, 2012